

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | sequestering of actin monomers (GO:0042989) | 7.15663337 |
| 2 | viral transcription (GO:0019083) | 6.63068305 |
| 3 | translational termination (GO:0006415) | 6.28832027 |
| 4 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 5.45516801 |
| 5 | translational elongation (GO:0006414) | 5.39170554 |
| 6 | protein targeting to ER (GO:0045047) | 5.33867427 |
| 7 | cotranslational protein targeting to membrane (GO:0006613) | 5.32389182 |
| 8 | ribosomal small subunit biogenesis (GO:0042274) | 5.31399659 |
| 9 | ribosomal small subunit assembly (GO:0000028) | 5.19683133 |
| 10 | viral life cycle (GO:0019058) | 5.16444459 |
| 11 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 5.06797796 |
| 12 | protein localization to endoplasmic reticulum (GO:0070972) | 5.06604364 |
| 13 | cellular protein complex disassembly (GO:0043624) | 5.03311850 |
| 14 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 4.46081072 |
| 15 | hemidesmosome assembly (GO:0031581) | 4.41208646 |
| 16 | response to water (GO:0009415) | 4.39729622 |
| 17 | translational initiation (GO:0006413) | 4.27973624 |
| 18 | proteasome assembly (GO:0043248) | 4.24484664 |
| 19 | protein maturation by protein folding (GO:0022417) | 4.14593579 |
| 20 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.09197701 |
| 21 | regulation of metalloenzyme activity (GO:0048552) | 4.05552662 |
| 22 | protein complex disassembly (GO:0043241) | 4.05390208 |
| 23 | ribosomal large subunit biogenesis (GO:0042273) | 3.93133364 |
| 24 | protein targeting to membrane (GO:0006612) | 3.86972560 |
| 25 | macromolecular complex disassembly (GO:0032984) | 3.80754869 |
| 26 | Golgi transport vesicle coating (GO:0048200) | 3.68901750 |
| 27 | COPI coating of Golgi vesicle (GO:0048205) | 3.68901750 |
| 28 | protein retention in ER lumen (GO:0006621) | 3.58062364 |
| 29 | maturation of SSU-rRNA (GO:0030490) | 3.57872575 |
| 30 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 3.50027828 |
| 31 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.46196683 |
| 32 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.46196683 |
| 33 | skin morphogenesis (GO:0043589) | 3.40586784 |
| 34 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 3.34376397 |
| 35 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.33839743 |
| 36 | barbed-end actin filament capping (GO:0051016) | 3.27066538 |
| 37 | translation (GO:0006412) | 3.10914552 |
| 38 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 3.10313747 |
| 39 | cellular response to nicotine (GO:0071316) | 3.01279601 |
| 40 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.01239013 |
| 41 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.97796640 |
| 42 | cellular response to zinc ion (GO:0071294) | 2.96354895 |
| 43 | pinocytosis (GO:0006907) | 2.94288658 |
| 44 | regulation of protein heterodimerization activity (GO:0043497) | 2.93138354 |
| 45 | pyrimidine-containing compound salvage (GO:0008655) | 2.92840991 |
| 46 | pyrimidine nucleoside salvage (GO:0043097) | 2.92840991 |
| 47 | neutrophil activation involved in immune response (GO:0002283) | 2.87528038 |
| 48 | actin nucleation (GO:0045010) | 2.86362111 |
| 49 | cellular copper ion homeostasis (GO:0006878) | 2.85342519 |
| 50 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 2.84413797 |
| 51 | protein neddylation (GO:0045116) | 2.81769517 |
| 52 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.81257713 |
| 53 | GDP-mannose metabolic process (GO:0019673) | 2.81144411 |
| 54 | positive regulation of epidermal cell differentiation (GO:0045606) | 2.80806380 |
| 55 | cytidine metabolic process (GO:0046087) | 2.79578261 |
| 56 | cytidine catabolic process (GO:0006216) | 2.79578261 |
| 57 | cytidine deamination (GO:0009972) | 2.79578261 |
| 58 | positive regulation of actin filament depolymerization (GO:0030836) | 2.77461108 |
| 59 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.76402836 |
| 60 | extracellular fibril organization (GO:0043206) | 2.75678229 |
| 61 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 2.75564805 |
| 62 | desmosome organization (GO:0002934) | 2.72086710 |
| 63 | nucleoside salvage (GO:0043174) | 2.71735163 |
| 64 | negative regulation of ligase activity (GO:0051352) | 2.71651047 |
| 65 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 2.71651047 |
| 66 | positive regulation of epidermis development (GO:0045684) | 2.71180408 |
| 67 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.71076974 |
| 68 | negative regulation of epidermal growth factor-activated receptor activity (GO:0007175) | 2.69829592 |
| 69 | nuclear-transcribed mRNA catabolic process (GO:0000956) | 2.69070773 |
| 70 | regulation of water loss via skin (GO:0033561) | 2.68271783 |
| 71 | fibril organization (GO:0097435) | 2.66762511 |
| 72 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 2.65578374 |
| 73 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 2.65578374 |
| 74 | cell adhesion mediated by integrin (GO:0033627) | 2.65199139 |
| 75 | aldehyde catabolic process (GO:0046185) | 2.65144811 |
| 76 | * establishment of protein localization to membrane (GO:0090150) | 2.64792802 |
| 77 | regulation of monocyte chemotaxis (GO:0090025) | 2.63787580 |
| 78 | regulation of transforming growth factor beta2 production (GO:0032909) | 2.63116782 |
| 79 | protein localization to endosome (GO:0036010) | 2.61562321 |
| 80 | phospholipid scrambling (GO:0017121) | 2.61320870 |
| 81 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.61255430 |
| 82 | response to interferon-beta (GO:0035456) | 2.60292641 |
| 83 | type B pancreatic cell proliferation (GO:0044342) | 2.58931664 |
| 84 | nucleotide-sugar biosynthetic process (GO:0009226) | 2.58419635 |
| 85 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 2.56958158 |
| 86 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 2.56958158 |
| 87 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 2.56958158 |
| 88 | nucleobase-containing small molecule interconversion (GO:0015949) | 2.56819892 |
| 89 | regulation of histone phosphorylation (GO:0033127) | 2.56616081 |
| 90 | cyclooxygenase pathway (GO:0019371) | 2.55597920 |
| 91 | phenol-containing compound catabolic process (GO:0019336) | 2.54701946 |
| 92 | negative regulation of protein autophosphorylation (GO:0031953) | 2.54496516 |
| 93 | galactose metabolic process (GO:0006012) | 2.54197022 |
| 94 | mRNA catabolic process (GO:0006402) | 2.53721973 |
| 95 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.50599816 |
| 96 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 2.48191477 |
| 97 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 2.48191477 |
| 98 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 2.47526230 |
| 99 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 2.46606043 |
| 100 | type I interferon signaling pathway (GO:0060337) | 2.46384443 |
| 101 | cellular response to type I interferon (GO:0071357) | 2.46384443 |
| 102 | response to type I interferon (GO:0034340) | 2.45710536 |
| 103 | keratan sulfate catabolic process (GO:0042340) | 2.45034637 |
| 104 | glycosphingolipid catabolic process (GO:0046479) | 2.43503839 |
| 105 | galactose catabolic process (GO:0019388) | 2.42908474 |
| 106 | regulation of interleukin-8 secretion (GO:2000482) | 2.39925529 |
| 107 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 2.37650711 |
| 108 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.37650640 |
| 109 | negative regulation of nitric-oxide synthase activity (GO:0051001) | 2.37231116 |
| 110 | regulation of cellular amine metabolic process (GO:0033238) | 2.37167810 |
| 111 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 2.36913177 |
| 112 | surfactant homeostasis (GO:0043129) | 2.36113985 |
| 113 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c (GO | 2.34354482 |
| 114 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 2.34249209 |
| 115 | response to peptidoglycan (GO:0032494) | 2.33564137 |
| 116 | regulation of necrotic cell death (GO:0010939) | 2.33425958 |
| 117 | regulation of integrin-mediated signaling pathway (GO:2001044) | 2.33174850 |
| 118 | T cell apoptotic process (GO:0070231) | 2.33040331 |
| 119 | actin filament depolymerization (GO:0030042) | 2.31662674 |
| 120 | dichotomous subdivision of an epithelial terminal unit (GO:0060600) | 2.31423365 |
| 121 | mitotic nuclear envelope reassembly (GO:0007084) | 2.31377592 |
| 122 | nuclear envelope reassembly (GO:0031468) | 2.31377592 |
| 123 | cellular response to interferon-alpha (GO:0035457) | 2.30688311 |
| 124 | positive regulation of extracellular matrix organization (GO:1903055) | 2.30060633 |
| 125 | protein targeting (GO:0006605) | 2.29867186 |
| 126 | positive regulation of reactive oxygen species metabolic process (GO:2000379) | 2.29807330 |
| 127 | hepatocyte apoptotic process (GO:0097284) | 2.28538445 |
| 128 | antigen processing and presentation of peptide antigen via MHC class I (GO:0002474) | 2.28524577 |
| 129 | positive regulation of monocyte chemotaxis (GO:0090026) | 2.28202751 |
| 130 | regulation of podosome assembly (GO:0071801) | 2.27712527 |
| 131 | response to copper ion (GO:0046688) | 2.26857088 |
| 132 | peptidyl-proline hydroxylation (GO:0019511) | 2.26699868 |
| 133 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 2.26687537 |
| 134 | regulation of cytokine secretion involved in immune response (GO:0002739) | 2.26528008 |
| 135 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 2.24897004 |
| 136 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.24386095 |
| 137 | cell-substrate junction assembly (GO:0007044) | 2.24321482 |
| 138 | detection of temperature stimulus involved in sensory perception of pain (GO:0050965) | 2.24299680 |
| 139 | detection of temperature stimulus involved in sensory perception (GO:0050961) | 2.24299680 |
| 140 | response to interferon-alpha (GO:0035455) | 2.23706866 |
| 141 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 2.22969924 |
| 142 | ATP synthesis coupled proton transport (GO:0015986) | 2.22969924 |
| 143 | glycolipid catabolic process (GO:0019377) | 2.22919858 |
| 144 | positive regulation of macrophage differentiation (GO:0045651) | 2.22648317 |
| 145 | positive regulation of lamellipodium assembly (GO:0010592) | 2.22582391 |
| 146 | * membrane budding (GO:0006900) | 2.22476864 |
| 147 | response to progesterone (GO:0032570) | 2.22146385 |
| 148 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.22033466 |
| 149 | oligosaccharide catabolic process (GO:0009313) | 2.21843807 |
| 150 | regulation of cellular amino acid metabolic process (GO:0006521) | 2.21708105 |
| 151 | RNA catabolic process (GO:0006401) | 2.21636659 |
| 152 | platelet aggregation (GO:0070527) | 2.21273405 |
| 153 | regulation of superoxide anion generation (GO:0032928) | 2.21127791 |
| 154 | mitochondrial calcium ion transport (GO:0006851) | 2.20880965 |
| 155 | hydrogen peroxide catabolic process (GO:0042744) | 2.20261887 |
| 156 | aggressive behavior (GO:0002118) | 2.19668244 |
| 157 | copper ion homeostasis (GO:0055070) | 2.19550089 |
| 158 | regulation of extracellular matrix disassembly (GO:0010715) | 2.19531021 |
| 159 | negative regulation of hydrogen peroxide-induced cell death (GO:1903206) | 2.19525879 |
| 160 | protein hydroxylation (GO:0018126) | 2.18715366 |
| 161 | leukocyte aggregation (GO:0070486) | 2.18638144 |
| 162 | positive regulation of ligase activity (GO:0051351) | 2.17852784 |
| 163 | negative regulation of type 2 immune response (GO:0002829) | 2.16405172 |
| 164 | establishment of skin barrier (GO:0061436) | 2.15685294 |
| 165 | detection of temperature stimulus (GO:0016048) | 2.14994428 |
| 166 | positive regulation of keratinocyte differentiation (GO:0045618) | 2.14439069 |
| 167 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.14255784 |
| 168 | protein autoprocessing (GO:0016540) | 2.13663522 |
| 169 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 2.13628051 |
| 170 | negative regulation of release of cytochrome c from mitochondria (GO:0090201) | 2.13101369 |
| 171 | * membrane raft organization (GO:0031579) | 2.12696600 |
| 172 | endodermal cell differentiation (GO:0035987) | 2.11717493 |
| 173 | regulation of natural killer cell differentiation (GO:0032823) | 2.10888845 |
| 174 | positive regulation of endothelial cell apoptotic process (GO:2000353) | 2.10836205 |
| 175 | positive regulation of hair cycle (GO:0042635) | 2.10566328 |
| 176 | positive regulation of hair follicle development (GO:0051798) | 2.10566328 |
| 177 | cellular response to interferon-beta (GO:0035458) | 2.10529575 |
| 178 | respiratory burst (GO:0045730) | 2.09781071 |
| 179 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 2.09643581 |
| 180 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 2.08338013 |
| 181 | T cell migration (GO:0072678) | 2.07210837 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 6.65031431 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.59089170 |
| 3 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.17710959 |
| 4 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 3.17648978 |
| 5 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.96415793 |
| 6 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.70147712 |
| 7 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.69177111 |
| 8 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.64527184 |
| 9 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.58437297 |
| 10 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.51449394 |
| 11 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.37183135 |
| 12 | * IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.35688101 |
| 13 | * SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 2.34425176 |
| 14 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.28855210 |
| 15 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.11326431 |
| 16 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 2.11295769 |
| 17 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.02938565 |
| 18 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.95708438 |
| 19 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.94176471 |
| 20 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.90114278 |
| 21 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.79497791 |
| 22 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.79393267 |
| 23 | * SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.79018521 |
| 24 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.77208343 |
| 25 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.73410067 |
| 26 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.73267248 |
| 27 | * ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.73254250 |
| 28 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.72690672 |
| 29 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.71179681 |
| 30 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.68110251 |
| 31 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.66105946 |
| 32 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.66082361 |
| 33 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.65235750 |
| 34 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.63362529 |
| 35 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.60656967 |
| 36 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.56464289 |
| 37 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.56436882 |
| 38 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.55867619 |
| 39 | * SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.53628653 |
| 40 | * SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.53628653 |
| 41 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.53422209 |
| 42 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.50562480 |
| 43 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.50326809 |
| 44 | * RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.50137763 |
| 45 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.47402571 |
| 46 | * MAF_26560356_Chip-Seq_TH1_Human | 1.46822166 |
| 47 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.45684262 |
| 48 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.45187601 |
| 49 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.44848697 |
| 50 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.44758117 |
| 51 | * STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.44639830 |
| 52 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.43660183 |
| 53 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.42404558 |
| 54 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.40007473 |
| 55 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.39124689 |
| 56 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.38719325 |
| 57 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.36814645 |
| 58 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.36760487 |
| 59 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.35908698 |
| 60 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.35129084 |
| 61 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.34678570 |
| 62 | * ATF3_27146783_Chip-Seq_COLON_Human | 1.34598376 |
| 63 | * FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.32836249 |
| 64 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.31555974 |
| 65 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.29689286 |
| 66 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.29624870 |
| 67 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.29104709 |
| 68 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 1.29083795 |
| 69 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.29078295 |
| 70 | MYB_26560356_Chip-Seq_TH2_Human | 1.27456907 |
| 71 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.26589540 |
| 72 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.26150701 |
| 73 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.24572195 |
| 74 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.23848048 |
| 75 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.22483642 |
| 76 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.22324820 |
| 77 | * GATA6_25053715_ChIP-Seq_YYC3_Human | 1.22093514 |
| 78 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.21676759 |
| 79 | * TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.21621673 |
| 80 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.20765864 |
| 81 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.20319619 |
| 82 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.20190391 |
| 83 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.19809839 |
| 84 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.19245307 |
| 85 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.18588143 |
| 86 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.18176753 |
| 87 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.18079339 |
| 88 | * EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 1.18030575 |
| 89 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.17943084 |
| 90 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.16955422 |
| 91 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.16867462 |
| 92 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.14446381 |
| 93 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.13887540 |
| 94 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.13662530 |
| 95 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.13573146 |
| 96 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.13523703 |
| 97 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.12943865 |
| 98 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.11774333 |
| 99 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.11256794 |
| 100 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.11202536 |
| 101 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.10870600 |
| 102 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.10533939 |
| 103 | * GATA4_25053715_ChIP-Seq_YYC3_Human | 1.09652677 |
| 104 | * HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.08977231 |
| 105 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.07410638 |
| 106 | * UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.07109114 |
| 107 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.06846555 |
| 108 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.06088194 |
| 109 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.06064974 |
| 110 | * UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.06036561 |
| 111 | * GATA3_24758297_ChIP-Seq_MCF-7_Human | 1.05554946 |
| 112 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.05520438 |
| 113 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.04700464 |
| 114 | * CLOCK_20551151_ChIP-Seq_293T_Human | 1.03845065 |
| 115 | ELF5_23300383_ChIP-Seq_T47D_Human | 1.03614460 |
| 116 | UTX_26944678_Chip-Seq_JUKART_Human | 1.03510262 |
| 117 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.03348856 |
| 118 | * MAF_26560356_Chip-Seq_TH2_Human | 1.01977876 |
| 119 | * CJUN_26792858_Chip-Seq_BT549_Human | 1.01708250 |
| 120 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.01482834 |
| 121 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.01414718 |
| 122 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.01245676 |
| 123 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.01023835 |
| 124 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.00746386 |
| 125 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 1.00459008 |
| 126 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 0.99970285 |
| 127 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.98518598 |
| 128 | MYB_26560356_Chip-Seq_TH1_Human | 0.98016408 |
| 129 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.95393594 |
| 130 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.94549976 |
| 131 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.89875646 |
| 132 | * ZFX_18555785_ChIP-Seq_MESCs_Mouse | 0.89315303 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0009379_abnormal_foot_pigmentation | 3.14956768 |
| 2 | MP0005275_abnormal_skin_tensile | 2.93951473 |
| 3 | MP0003950_abnormal_plasma_membrane | 2.91970527 |
| 4 | MP0008438_abnormal_cutaneous_collagen | 2.89737764 |
| 5 | MP0003436_decreased_susceptibility_to | 2.86186842 |
| 6 | MP0001835_abnormal_antigen_presentation | 2.58902071 |
| 7 | MP0009785_altered_susceptibility_to | 2.47667735 |
| 8 | MP0003705_abnormal_hypodermis_morpholog | 2.41435896 |
| 9 | MP0002877_abnormal_melanocyte_morpholog | 2.35051561 |
| 10 | MP0003724_increased_susceptibility_to | 2.28461520 |
| 11 | MP0002148_abnormal_hypersensitivity_rea | 2.24565888 |
| 12 | MP0003566_abnormal_cell_adhesion | 2.19776265 |
| 13 | MP0005058_abnormal_lysosome_morphology | 2.16438973 |
| 14 | MP0005000_abnormal_immune_tolerance | 1.99020539 |
| 15 | MP0005671_abnormal_response_to | 1.97952666 |
| 16 | MP0002166_altered_tumor_susceptibility | 1.89690076 |
| 17 | MP0005025_abnormal_response_to | 1.87037015 |
| 18 | MP0005023_abnormal_wound_healing | 1.82827263 |
| 19 | MP0000685_abnormal_immune_system | 1.82808336 |
| 20 | MP0004947_skin_inflammation | 1.82643003 |
| 21 | MP0000858_altered_metastatic_potential | 1.81601550 |
| 22 | MP0010352_gastrointestinal_tract_polyps | 1.76328744 |
| 23 | MP0001533_abnormal_skeleton_physiology | 1.76162355 |
| 24 | MP0002006_tumorigenesis | 1.74316975 |
| 25 | MP0010155_abnormal_intestine_physiology | 1.71928220 |
| 26 | MP0002060_abnormal_skin_morphology | 1.69209644 |
| 27 | MP0000372_irregular_coat_pigmentation | 1.68103414 |
| 28 | MP0001853_heart_inflammation | 1.66402783 |
| 29 | MP0005503_abnormal_tendon_morphology | 1.65922272 |
| 30 | MP0004264_abnormal_extraembryonic_tissu | 1.63207053 |
| 31 | MP0005257_abnormal_intraocular_pressure | 1.62312418 |
| 32 | MP0008260_abnormal_autophagy | 1.57847768 |
| 33 | MP0002419_abnormal_innate_immunity | 1.57613384 |
| 34 | MP0003279_aneurysm | 1.57145747 |
| 35 | MP0001800_abnormal_humoral_immune | 1.56501476 |
| 36 | MP0005387_immune_system_phenotype | 1.56134718 |
| 37 | MP0001790_abnormal_immune_system | 1.56134718 |
| 38 | MP0002933_joint_inflammation | 1.55572004 |
| 39 | MP0002452_abnormal_antigen_presenting | 1.54205940 |
| 40 | MP0002796_impaired_skin_barrier | 1.54141997 |
| 41 | MP0003941_abnormal_skin_development | 1.53822746 |
| 42 | MP0001542_abnormal_bone_strength | 1.53491684 |
| 43 | MP0006082_CNS_inflammation | 1.52143262 |
| 44 | MP0002405_respiratory_system_inflammati | 1.51402184 |
| 45 | MP0005165_increased_susceptibility_to | 1.51315079 |
| 46 | MP0000762_abnormal_tongue_morphology | 1.50211875 |
| 47 | MP0002723_abnormal_immune_serum | 1.49706348 |
| 48 | MP0003186_abnormal_redox_activity | 1.49635190 |
| 49 | MP0009333_abnormal_splenocyte_physiolog | 1.47804613 |
| 50 | MP0003300_gastrointestinal_ulcer | 1.46699302 |
| 51 | MP0001819_abnormal_immune_cell | 1.45893204 |
| 52 | MP0002420_abnormal_adaptive_immunity | 1.45116915 |
| 53 | MP0005464_abnormal_platelet_physiology | 1.43024466 |
| 54 | MP0003866_abnormal_defecation | 1.41299936 |
| 55 | MP0001845_abnormal_inflammatory_respons | 1.41012148 |
| 56 | MP0000343_altered_response_to | 1.39908540 |
| 57 | MP0004858_abnormal_nervous_system | 1.36707622 |
| 58 | MP0010234_abnormal_vibrissa_follicle | 1.36203060 |
| 59 | MP0003075_altered_response_to | 1.35121697 |
| 60 | MP0003453_abnormal_keratinocyte_physiol | 1.33882028 |
| 61 | MP0003763_abnormal_thymus_physiology | 1.32994912 |
| 62 | MP0003828_pulmonary_edema | 1.32229013 |
| 63 | MP0000538_abnormal_urinary_bladder | 1.31923436 |
| 64 | MP0005166_decreased_susceptibility_to | 1.29321979 |
| 65 | MP0002132_abnormal_respiratory_system | 1.25380651 |
| 66 | MP0005451_abnormal_body_composition | 1.22924988 |
| 67 | MP0005390_skeleton_phenotype | 1.20435338 |
| 68 | MP0001243_abnormal_dermal_layer | 1.20434001 |
| 69 | MP0010678_abnormal_skin_adnexa | 1.18612888 |
| 70 | MP0000467_abnormal_esophagus_morphology | 1.17055888 |
| 71 | MP0000579_abnormal_nail_morphology | 1.16931139 |
| 72 | MP0002254_reproductive_system_inflammat | 1.16556911 |
| 73 | MP0009053_abnormal_anal_canal | 1.15917091 |
| 74 | MP0001216_abnormal_epidermal_layer | 1.14590422 |
| 75 | MP0003693_abnormal_embryo_hatching | 1.14457347 |
| 76 | MP0003448_altered_tumor_morphology | 1.13278010 |
| 77 | MP0005501_abnormal_skin_physiology | 1.12150982 |
| 78 | MP0010030_abnormal_orbit_morphology | 1.12043059 |
| 79 | MP0008469_abnormal_protein_level | 1.11164809 |
| 80 | MP0010386_abnormal_urinary_bladder | 1.08241146 |
| 81 | MP0005408_hypopigmentation | 1.06907368 |
| 82 | MP0003656_abnormal_erythrocyte_physiolo | 1.05907931 |
| 83 | MP0004272_abnormal_basement_membrane | 1.05595238 |
| 84 | MP0005360_urolithiasis | 1.04258894 |
| 85 | MP0000627_abnormal_mammary_gland | 1.02921668 |
| 86 | MP0005083_abnormal_biliary_tract | 1.02767844 |
| 87 | MP0002098_abnormal_vibrissa_morphology | 1.02096522 |
| 88 | MP0000490_abnormal_crypts_of | 1.01941701 |
| 89 | MP0009764_decreased_sensitivity_to | 1.01860555 |
| 90 | MP0000716_abnormal_immune_system | 1.01424093 |
| 91 | MP0002398_abnormal_bone_marrow | 1.00856919 |
| 92 | MP0001881_abnormal_mammary_gland | 1.00736439 |
| 93 | MP0001663_abnormal_digestive_system | 1.00509267 |
| 94 | MP0002282_abnormal_trachea_morphology | 0.99870729 |
| 95 | MP0002139_abnormal_hepatobiliary_system | 0.99635503 |
| 96 | MP0002998_abnormal_bone_remodeling | 0.98998264 |
| 97 | MP0000678_abnormal_parathyroid_gland | 0.98960500 |
| 98 | MP0004233_abnormal_muscle_weight | 0.98943986 |
| 99 | MP0001873_stomach_inflammation | 0.98843899 |
| 100 | MP0001348_abnormal_lacrimal_gland | 0.98241970 |
| 101 | MP0002735_abnormal_chemical_nociception | 0.98098147 |
| 102 | MP0005397_hematopoietic_system_phenotyp | 0.97951990 |
| 103 | MP0001545_abnormal_hematopoietic_system | 0.97951990 |
| 104 | MP0003091_abnormal_cell_migration | 0.95779276 |
| 105 | MP0010771_integument_phenotype | 0.95750069 |
| 106 | MP0003191_abnormal_cellular_cholesterol | 0.92568968 |
| 107 | MP0006054_spinal_hemorrhage | 0.92567454 |
| 108 | MP0000465_gastrointestinal_hemorrhage | 0.92542578 |
| 109 | MP0001849_ear_inflammation | 0.91860798 |
| 110 | MP0004782_abnormal_surfactant_physiolog | 0.91851139 |
| 111 | MP0008004_abnormal_stomach_pH | 0.91314674 |
| 112 | MP0002722_abnormal_immune_system | 0.90858762 |
| 113 | MP0003806_abnormal_nucleotide_metabolis | 0.90799102 |
| 114 | MP0005330_cardiomyopathy | 0.88504129 |
| 115 | MP0010368_abnormal_lymphatic_system | 0.88106957 |
| 116 | MP0005367_renal/urinary_system_phenotyp | 0.87998634 |
| 117 | MP0000516_abnormal_urinary_system | 0.87998634 |
| 118 | MP0002429_abnormal_blood_cell | 0.87929663 |
| 119 | MP0001958_emphysema | 0.87410392 |
| 120 | MP0009780_abnormal_chondrocyte_physiolo | 0.85936326 |
| 121 | MP0002138_abnormal_hepatobiliary_system | 0.85265138 |
| 122 | MP0003795_abnormal_bone_structure | 0.83281978 |
| 123 | MP0009931_abnormal_skin_appearance | 0.82730423 |
| 124 | MP0005164_abnormal_response_to | 0.82017062 |
| 125 | MP0003303_peritoneal_inflammation | 0.81711504 |
| 126 | MP0003045_fibrosis | 0.81383129 |
| 127 | MP0002896_abnormal_bone_mineralization | 0.80865973 |
| 128 | MP0004019_abnormal_vitamin_homeostasis | 0.80854328 |
| 129 | MP0002332_abnormal_exercise_endurance | 0.80130475 |
| 130 | MP0000689_abnormal_spleen_morphology | 0.80090278 |
| 131 | MP0004883_abnormal_blood_vessel | 0.79529376 |
| 132 | MP0000750_abnormal_muscle_regeneration | 0.79086757 |
| 133 | MP0000377_abnormal_hair_follicle | 0.78697544 |
| 134 | MP0000537_abnormal_urethra_morphology | 0.77983749 |
| 135 | MP0009840_abnormal_foam_cell | 0.77855133 |
| 136 | MP0008875_abnormal_xenobiotic_pharmacok | 0.76605813 |
| 137 | MP0005197_abnormal_uvea_morphology | 0.75998400 |
| 138 | MP0005670_abnormal_white_adipose | 0.74185730 |
| 139 | MP0002751_abnormal_autonomic_nervous | 0.74141823 |
| 140 | MP0001851_eye_inflammation | 0.74028883 |
| 141 | MP0000249_abnormal_blood_vessel | 0.73115108 |
| 142 | MP0000767_abnormal_smooth_muscle | 0.72074682 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormal hemoglobin (HP:0011902) | 4.42583499 |
| 2 | Abnormality of cells of the erythroid lineage (HP:0012130) | 4.41222480 |
| 3 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.66719585 |
| 4 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.66719585 |
| 5 | Abnormality of glycolipid metabolism (HP:0010969) | 3.66719585 |
| 6 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.58551144 |
| 7 | Right ventricular cardiomyopathy (HP:0011663) | 3.51996748 |
| 8 | Reduced subcutaneous adipose tissue (HP:0003758) | 3.38629855 |
| 9 | Amyloidosis (HP:0011034) | 3.37816521 |
| 10 | Protrusio acetabuli (HP:0003179) | 3.21568851 |
| 11 | Hypothermia (HP:0002045) | 3.19989499 |
| 12 | Vertebral compression fractures (HP:0002953) | 3.18909030 |
| 13 | Eczematoid dermatitis (HP:0000976) | 3.13087904 |
| 14 | Fragile nails (HP:0001808) | 3.12514822 |
| 15 | Distal lower limb muscle weakness (HP:0009053) | 3.06381108 |
| 16 | Abnormal number of erythroid precursors (HP:0012131) | 3.05360419 |
| 17 | Pallor (HP:0000980) | 2.92794932 |
| 18 | Atrophic scars (HP:0001075) | 2.91714122 |
| 19 | Myotonia (HP:0002486) | 2.87924480 |
| 20 | Pustule (HP:0200039) | 2.86703657 |
| 21 | Myositis (HP:0100614) | 2.85936683 |
| 22 | Osteolytic defects of the hand bones (HP:0009699) | 2.79650390 |
| 23 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.79650390 |
| 24 | Vascular calcification (HP:0004934) | 2.77879477 |
| 25 | Trismus (HP:0000211) | 2.77584316 |
| 26 | Cardiovascular calcification (HP:0011915) | 2.71808094 |
| 27 | Glucose intolerance (HP:0000833) | 2.70226609 |
| 28 | Recurrent abscess formation (HP:0002722) | 2.69929315 |
| 29 | Macrocytic anemia (HP:0001972) | 2.68987064 |
| 30 | Premature rupture of membranes (HP:0001788) | 2.68825620 |
| 31 | Congenital ichthyosiform erythroderma (HP:0007431) | 2.64302563 |
| 32 | Reticulocytopenia (HP:0001896) | 2.63232985 |
| 33 | Peritonitis (HP:0002586) | 2.60022631 |
| 34 | Rough bone trabeculation (HP:0100670) | 2.51224106 |
| 35 | Alopecia of scalp (HP:0002293) | 2.47932903 |
| 36 | Beaking of vertebral bodies (HP:0004568) | 2.46655806 |
| 37 | Increased connective tissue (HP:0009025) | 2.41943254 |
| 38 | Thoracolumbar scoliosis (HP:0002944) | 2.39102693 |
| 39 | Nail dystrophy (HP:0008404) | 2.38846004 |
| 40 | Orchitis (HP:0100796) | 2.37675981 |
| 41 | Fragile skin (HP:0001030) | 2.36238408 |
| 42 | Recurrent bacterial skin infections (HP:0005406) | 2.34736519 |
| 43 | Plantar hyperkeratosis (HP:0007556) | 2.33301352 |
| 44 | Abnormality of placental membranes (HP:0011409) | 2.33199748 |
| 45 | Amniotic constriction ring (HP:0009775) | 2.33199748 |
| 46 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 2.33032183 |
| 47 | Onycholysis (HP:0001806) | 2.32608554 |
| 48 | Short nail (HP:0001799) | 2.29306384 |
| 49 | Milia (HP:0001056) | 2.26994655 |
| 50 | Hypokinesia (HP:0002375) | 2.22198903 |
| 51 | Dysostosis multiplex (HP:0000943) | 2.22051552 |
| 52 | Distal lower limb amyotrophy (HP:0008944) | 2.21847530 |
| 53 | Malnutrition (HP:0004395) | 2.19117508 |
| 54 | Spondylolisthesis (HP:0003302) | 2.18983267 |
| 55 | Cervical subluxation (HP:0003308) | 2.17438595 |
| 56 | Woolly hair (HP:0002224) | 2.13920615 |
| 57 | Vacuolated lymphocytes (HP:0001922) | 2.13395776 |
| 58 | Nuclear cataract (HP:0100018) | 2.13316490 |
| 59 | Ulnar claw (HP:0001178) | 2.13070030 |
| 60 | Myokymia (HP:0002411) | 2.10474245 |
| 61 | Micronodular cirrhosis (HP:0001413) | 2.09842154 |
| 62 | Abnormality of nail color (HP:0100643) | 2.09069343 |
| 63 | Mesangial abnormality (HP:0001966) | 2.06379170 |
| 64 | Abnormal trabecular bone morphology (HP:0100671) | 2.05998432 |
| 65 | Acanthosis nigricans (HP:0000956) | 2.04718806 |
| 66 | Biconcave vertebral bodies (HP:0004586) | 2.04698413 |
| 67 | Down-sloping shoulders (HP:0200021) | 2.04667151 |
| 68 | Interstitial pulmonary disease (HP:0006530) | 2.04552753 |
| 69 | Entropion (HP:0000621) | 2.02858629 |
| 70 | Cupped ribs (HP:0000887) | 2.02165626 |
| 71 | Prolonged neonatal jaundice (HP:0006579) | 2.01536952 |
| 72 | Petechiae (HP:0000967) | 2.01041306 |
| 73 | Vascular tortuosity (HP:0004948) | 2.00208879 |
| 74 | Thick nail (HP:0001805) | 2.00044813 |
| 75 | Abnormal blistering of the skin (HP:0008066) | 1.99391489 |
| 76 | Abnormal tarsal ossification (HP:0008369) | 1.99287668 |
| 77 | Pili torti (HP:0003777) | 1.99147717 |
| 78 | Palpitations (HP:0001962) | 1.99016009 |
| 79 | Hepatosplenomegaly (HP:0001433) | 1.98403366 |
| 80 | Progressive neurologic deterioration (HP:0002344) | 1.98155570 |
| 81 | Abnormalities of placenta or umbilical cord (HP:0001194) | 1.98153069 |
| 82 | Flat acetabular roof (HP:0003180) | 1.96159542 |
| 83 | Aortic dissection (HP:0002647) | 1.96075780 |
| 84 | Arterial tortuosity (HP:0005116) | 1.95987230 |
| 85 | Coxa vara (HP:0002812) | 1.94976030 |
| 86 | Axonal loss (HP:0003447) | 1.94938428 |
| 87 | Purpura (HP:0000979) | 1.94480191 |
| 88 | Nasal polyposis (HP:0100582) | 1.94208540 |
| 89 | Mitral stenosis (HP:0001718) | 1.93113237 |
| 90 | Spinal cord compression (HP:0002176) | 1.93088500 |
| 91 | Wormian bones (HP:0002645) | 1.92871196 |
| 92 | Anhidrosis (HP:0000970) | 1.90822409 |
| 93 | Loss of speech (HP:0002371) | 1.90705699 |
| 94 | Abnormality of the umbilical cord (HP:0010881) | 1.89717505 |
| 95 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.89625427 |
| 96 | Abnormal hair laboratory examination (HP:0003328) | 1.89521136 |
| 97 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.87822615 |
| 98 | Ankle contracture (HP:0006466) | 1.87069094 |
| 99 | Congenital, generalized hypertrichosis (HP:0004540) | 1.85446156 |
| 100 | Distal arthrogryposis (HP:0005684) | 1.85391815 |
| 101 | Abnormal foot bone ossification (HP:0010675) | 1.83998105 |
| 102 | Neonatal short-limb short stature (HP:0008921) | 1.83533260 |
| 103 | Abnormal glucose tolerance (HP:0001952) | 1.83207876 |
| 104 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.82332911 |
| 105 | Mucopolysacchariduria (HP:0008155) | 1.82332911 |
| 106 | Abnormal platelet volume (HP:0011876) | 1.81564604 |
| 107 | Radial bowing (HP:0002986) | 1.81304993 |
| 108 | Irregular epiphyses (HP:0010582) | 1.81247808 |
| 109 | Conjunctival hamartoma (HP:0100780) | 1.81031868 |
| 110 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.80270597 |
| 111 | Increased mean platelet volume (HP:0011877) | 1.80130818 |
| 112 | Abnormal mitochondria in muscle tissue (HP:0008316) | 1.79561811 |
| 113 | Natal tooth (HP:0000695) | 1.79081974 |
| 114 | Systemic lupus erythematosus (HP:0002725) | 1.78996471 |
| 115 | Retrobulbar optic neuritis (HP:0100654) | 1.78866700 |
| 116 | Optic neuritis (HP:0100653) | 1.78866700 |
| 117 | Erythema (HP:0010783) | 1.78411890 |
| 118 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.78312505 |
| 119 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.78312505 |
| 120 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.78312505 |
| 121 | Abnormality of carpal bone ossification (HP:0006257) | 1.76685327 |
| 122 | Oral leukoplakia (HP:0002745) | 1.75684689 |
| 123 | Skin ulcer (HP:0200042) | 1.75485790 |
| 124 | Neoplasm of head and neck (HP:0012288) | 1.75199862 |
| 125 | Esophageal neoplasm (HP:0100751) | 1.75199862 |
| 126 | Dilatation of the ascending aorta (HP:0005111) | 1.73659100 |
| 127 | Spinal rigidity (HP:0003306) | 1.73545949 |
| 128 | Hypercortisolism (HP:0001578) | 1.72640560 |
| 129 | Vasculitis (HP:0002633) | 1.72443584 |
| 130 | Palmar hyperkeratosis (HP:0010765) | 1.72394159 |
| 131 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.71799294 |
| 132 | Abnormality of the nasal mucosa (HP:0000433) | 1.71755660 |
| 133 | Abnormality of macrophages (HP:0004311) | 1.71622422 |
| 134 | Hydroxyprolinuria (HP:0003080) | 1.71587633 |
| 135 | Abnormality of proline metabolism (HP:0010907) | 1.71587633 |
| 136 | Recurrent fungal infections (HP:0002841) | 1.71568081 |
| 137 | Thrombocytosis (HP:0001894) | 1.71463265 |
| 138 | Orthostatic hypotension (HP:0001278) | 1.71193538 |
| 139 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 1.70589308 |
| 140 | Hypotrichosis (HP:0001006) | 1.70583331 |
| 141 | Follicular hyperkeratosis (HP:0007502) | 1.70583252 |
| 142 | Hepatocellular necrosis (HP:0001404) | 1.69660049 |
| 143 | Popliteal pterygium (HP:0009756) | 1.69637799 |
| 144 | Bone pain (HP:0002653) | 1.69157128 |
| 145 | Hyperhidrosis (HP:0000975) | 1.68561463 |
| 146 | Type I transferrin isoform profile (HP:0003642) | 1.68467984 |
| 147 | Selective tooth agenesis (HP:0001592) | 1.68324385 |
| 148 | Generalized amyotrophy (HP:0003700) | 1.67887888 |
| 149 | Hypoalphalipoproteinemia (HP:0003233) | 1.67409701 |
| 150 | Elbow flexion contracture (HP:0002987) | 1.67260250 |
| 151 | Abnormality of complement system (HP:0005339) | 1.66840875 |
| 152 | Autoamputation (HP:0001218) | 1.66579871 |
| 153 | Aplasia/Hypoplasia of the vertebrae (HP:0008515) | 1.66548318 |
| 154 | Vertebral hypoplasia (HP:0008417) | 1.66548318 |
| 155 | Sparse eyelashes (HP:0000653) | 1.66483863 |
| 156 | Short clavicles (HP:0000894) | 1.65499151 |
| 157 | Myocardial infarction (HP:0001658) | 1.65436361 |
| 158 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 1.65400565 |
| 159 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 1.65400565 |
| 160 | Palmoplantar hyperkeratosis (HP:0000972) | 1.64378874 |
| 161 | Acute necrotizing encephalopathy (HP:0006965) | 1.63574420 |
| 162 | Abnormal cartilage morphology (HP:0002763) | 1.62952836 |
| 163 | Autoimmune thrombocytopenia (HP:0001973) | 1.62754623 |
| 164 | Neck muscle weakness (HP:0000467) | 1.62474020 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NME2 | 5.72855859 |
| 2 | PIM2 | 3.80437869 |
| 3 | TESK1 | 3.16147198 |
| 4 | GRK5 | 2.65187160 |
| 5 | LIMK1 | 2.62616729 |
| 6 | MST4 | 2.52784142 |
| 7 | IRAK3 | 2.49226938 |
| 8 | MAPKAPK3 | 2.36764651 |
| 9 | TESK2 | 2.27871631 |
| 10 | MST1R | 2.25517406 |
| 11 | LRRK2 | 2.23809377 |
| 12 | TBK1 | 1.87358852 |
| 13 | RPS6KB2 | 1.70626553 |
| 14 | TYK2 | 1.67060915 |
| 15 | MAP3K3 | 1.60660084 |
| 16 | MAP4K1 | 1.59199084 |
| 17 | MAP3K12 | 1.57748042 |
| 18 | ARAF | 1.57680349 |
| 19 | ERN1 | 1.52728313 |
| 20 | MAP3K2 | 1.49298812 |
| 21 | MATK | 1.47418828 |
| 22 | KDR | 1.46402026 |
| 23 | MAP3K14 | 1.45582875 |
| 24 | BLK | 1.41961548 |
| 25 | MAP2K2 | 1.39297210 |
| 26 | ZAP70 | 1.38047508 |
| 27 | NEK9 | 1.37781450 |
| 28 | TRIB3 | 1.35272990 |
| 29 | TRPM7 | 1.32929236 |
| 30 | JAK3 | 1.28157670 |
| 31 | ILK | 1.25260350 |
| 32 | EPHB2 | 1.22128606 |
| 33 | EPHA2 | 1.21918313 |
| 34 | STK10 | 1.21754915 |
| 35 | FGFR4 | 1.18641655 |
| 36 | PDK2 | 1.14353656 |
| 37 | NME1 | 1.13640350 |
| 38 | BMPR2 | 1.13361688 |
| 39 | TAOK2 | 1.12490735 |
| 40 | NEK1 | 1.10314092 |
| 41 | VRK2 | 1.08516931 |
| 42 | BUB1 | 1.08301663 |
| 43 | STK16 | 1.06877452 |
| 44 | SCYL2 | 1.06778061 |
| 45 | TTN | 1.06387082 |
| 46 | RPS6KA4 | 1.05236087 |
| 47 | TXK | 1.04467973 |
| 48 | TGFBR1 | 1.04250093 |
| 49 | TEC | 1.03506433 |
| 50 | MAP2K1 | 1.02066307 |
| 51 | PRKG2 | 1.01948258 |
| 52 | MAP2K3 | 1.01878933 |
| 53 | MAP3K11 | 1.01330687 |
| 54 | EPHB1 | 1.00806676 |
| 55 | DAPK1 | 0.99587366 |
| 56 | NTRK1 | 0.99437675 |
| 57 | ERBB4 | 0.97096721 |
| 58 | IKBKB | 0.96304273 |
| 59 | GRK7 | 0.94372405 |
| 60 | PKN2 | 0.93952123 |
| 61 | IKBKE | 0.92549197 |
| 62 | ABL2 | 0.87187038 |
| 63 | KIT | 0.85550191 |
| 64 | JAK1 | 0.83310147 |
| 65 | CDK8 | 0.81646905 |
| 66 | MYLK | 0.81035209 |
| 67 | PIM1 | 0.80551761 |
| 68 | MOS | 0.80284023 |
| 69 | SIK1 | 0.80007288 |
| 70 | EPHA3 | 0.79605081 |
| 71 | PBK | 0.74554781 |
| 72 | ITK | 0.73271855 |
| 73 | TRIM28 | 0.73271056 |
| 74 | DDR2 | 0.73167301 |
| 75 | PIK3CA | 0.72649514 |
| 76 | KSR2 | 0.71711717 |
| 77 | PDGFRA | 0.68525007 |
| 78 | TLK1 | 0.68249466 |
| 79 | MAPKAPK5 | 0.64612276 |
| 80 | LCK | 0.62486743 |
| 81 | MARK3 | 0.62293134 |
| 82 | MUSK | 0.61440216 |
| 83 | BTK | 0.61212369 |
| 84 | PAK4 | 0.60826643 |
| 85 | GRK6 | 0.60355604 |
| 86 | ADRBK1 | 0.60154309 |
| 87 | BMPR1B | 0.59747820 |
| 88 | FLT3 | 0.59186780 |
| 89 | TGFBR2 | 0.58689138 |
| 90 | DAPK3 | 0.56960096 |
| 91 | RIPK1 | 0.56200078 |
| 92 | LATS1 | 0.55883712 |
| 93 | CSF1R | 0.55117613 |
| 94 | EIF2AK3 | 0.55081754 |
| 95 | FER | 0.54349808 |
| 96 | PIK3CG | 0.53837976 |
| 97 | CSK | 0.53529467 |
| 98 | LATS2 | 0.53418717 |
| 99 | EIF2AK1 | 0.52706596 |
| 100 | MAPKAPK2 | 0.52629701 |
| 101 | STK24 | 0.52257287 |
| 102 | CAMK2G | 0.52113604 |
| 103 | LMTK2 | 0.51126926 |
| 104 | PTK2 | 0.51059106 |
| 105 | MAP3K1 | 0.50001378 |
| 106 | SYK | 0.49197568 |
| 107 | MAP3K9 | 0.49149322 |
| 108 | CAMKK2 | 0.48797949 |
| 109 | EEF2K | 0.48789881 |
| 110 | BCKDK | 0.48181773 |
| 111 | STK38 | 0.47963731 |
| 112 | MAP3K8 | 0.47468985 |
| 113 | ERBB3 | 0.47288061 |
| 114 | RET | 0.47024485 |
| 115 | ROCK2 | 0.46912214 |
| 116 | FGFR3 | 0.44908795 |
| 117 | HCK | 0.43816290 |
| 118 | PRPF4B | 0.43781021 |
| 119 | MAPK4 | 0.43276458 |
| 120 | SIK3 | 0.42908432 |
| 121 | MET | 0.42353330 |
| 122 | PAK1 | 0.42248212 |
| 123 | PRKCI | 0.41545741 |
| 124 | ROCK1 | 0.41230752 |
| 125 | TAOK1 | 0.40567334 |
| 126 | PTK6 | 0.40047818 |
| 127 | FRK | 0.39542485 |
| 128 | NLK | 0.39375264 |
| 129 | BRAF | 0.37423056 |
| 130 | BMX | 0.37345994 |
| 131 | JAK2 | 0.36466854 |
| 132 | CAMK2D | 0.36017465 |
| 133 | BCR | 0.34826411 |
| 134 | DMPK | 0.32021256 |
| 135 | PAK2 | 0.29283715 |
| 136 | MELK | 0.28637738 |
| 137 | STK38L | 0.28342228 |
| 138 | PDPK1 | 0.26732861 |
| 139 | ABL1 | 0.26513044 |
| 140 | EGFR | 0.26478552 |
| 141 | PRKCD | 0.25201110 |
| 142 | AURKB | 0.24677239 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Ribosome_Homo sapiens_hsa03010 | 5.91845344 |
| 2 | Proteasome_Homo sapiens_hsa03050 | 3.31496301 |
| 3 | Other glycan degradation_Homo sapiens_hsa00511 | 2.51195512 |
| 4 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.46525352 |
| 5 | Galactose metabolism_Homo sapiens_hsa00052 | 2.36350950 |
| 6 | Parkinsons disease_Homo sapiens_hsa05012 | 2.35888019 |
| 7 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.04841052 |
| 8 | Leishmaniasis_Homo sapiens_hsa05140 | 1.94156221 |
| 9 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.92704908 |
| 10 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.91833624 |
| 11 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.89924527 |
| 12 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.89077816 |
| 13 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.79199511 |
| 14 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.76432346 |
| 15 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.72710564 |
| 16 | Lysosome_Homo sapiens_hsa04142 | 1.58775539 |
| 17 | Pertussis_Homo sapiens_hsa05133 | 1.54836746 |
| 18 | Salmonella infection_Homo sapiens_hsa05132 | 1.54737763 |
| 19 | Alzheimers disease_Homo sapiens_hsa05010 | 1.54081986 |
| 20 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.49904154 |
| 21 | Shigellosis_Homo sapiens_hsa05131 | 1.49059464 |
| 22 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.48439524 |
| 23 | Legionellosis_Homo sapiens_hsa05134 | 1.44355085 |
| 24 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.42608171 |
| 25 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.40395085 |
| 26 | Malaria_Homo sapiens_hsa05144 | 1.37808895 |
| 27 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.37549198 |
| 28 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.36779014 |
| 29 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.35742128 |
| 30 | Allograft rejection_Homo sapiens_hsa05330 | 1.33907441 |
| 31 | Huntingtons disease_Homo sapiens_hsa05016 | 1.33367100 |
| 32 | Thyroid cancer_Homo sapiens_hsa05216 | 1.32979318 |
| 33 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.31757280 |
| 34 | Apoptosis_Homo sapiens_hsa04210 | 1.26627993 |
| 35 | Phagosome_Homo sapiens_hsa04145 | 1.24615235 |
| 36 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.23213606 |
| 37 | Measles_Homo sapiens_hsa05162 | 1.23118437 |
| 38 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.21287482 |
| 39 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.21027139 |
| 40 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.19474694 |
| 41 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.19117733 |
| 42 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.17640177 |
| 43 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.15406277 |
| 44 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.13208029 |
| 45 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.11586407 |
| 46 | Viral myocarditis_Homo sapiens_hsa05416 | 1.11404291 |
| 47 | Tuberculosis_Homo sapiens_hsa05152 | 1.11055659 |
| 48 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.08469930 |
| 49 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.07985099 |
| 50 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.07487176 |
| 51 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.05865136 |
| 52 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.05597785 |
| 53 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.04413060 |
| 54 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.04360114 |
| 55 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.02060813 |
| 56 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.99154057 |
| 57 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.98109253 |
| 58 | Amoebiasis_Homo sapiens_hsa05146 | 0.97643276 |
| 59 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.96712145 |
| 60 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.95903185 |
| 61 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.95704290 |
| 62 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.92802714 |
| 63 | Bladder cancer_Homo sapiens_hsa05219 | 0.92645430 |
| 64 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.92394810 |
| 65 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.90885391 |
| 66 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.90049350 |
| 67 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.81291180 |
| 68 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.80176319 |
| 69 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.78338678 |
| 70 | Protein export_Homo sapiens_hsa03060 | 0.77622665 |
| 71 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.76123578 |
| 72 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.75760001 |
| 73 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.75563704 |
| 74 | Endocytosis_Homo sapiens_hsa04144 | 0.75388018 |
| 75 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.74704550 |
| 76 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.74235357 |
| 77 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.73598285 |
| 78 | Influenza A_Homo sapiens_hsa05164 | 0.73389263 |
| 79 | Histidine metabolism_Homo sapiens_hsa00340 | 0.73238368 |
| 80 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.73206864 |
| 81 | Sulfur relay system_Homo sapiens_hsa04122 | 0.71294244 |
| 82 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.70685670 |
| 83 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.69702901 |
| 84 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.68609962 |
| 85 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.68472243 |
| 86 | Platelet activation_Homo sapiens_hsa04611 | 0.67284638 |
| 87 | Hepatitis B_Homo sapiens_hsa05161 | 0.67193135 |
| 88 | Carbon metabolism_Homo sapiens_hsa01200 | 0.65929278 |
| 89 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.65618231 |
| 90 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.64155497 |
| 91 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.64128081 |
| 92 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.63500565 |
| 93 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.63416469 |
| 94 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.63173440 |
| 95 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.63149512 |
| 96 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.62814649 |
| 97 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.62447669 |
| 98 | Focal adhesion_Homo sapiens_hsa04510 | 0.61779046 |
| 99 | Adherens junction_Homo sapiens_hsa04520 | 0.60892257 |
| 100 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.59985055 |
| 101 | Hepatitis C_Homo sapiens_hsa05160 | 0.59904425 |
| 102 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.58498483 |
| 103 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.57711273 |
| 104 | RNA polymerase_Homo sapiens_hsa03020 | 0.56392685 |
| 105 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.55997891 |
| 106 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.55669095 |
| 107 | Asthma_Homo sapiens_hsa05310 | 0.55384033 |
| 108 | Mineral absorption_Homo sapiens_hsa04978 | 0.52659772 |
| 109 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.49995427 |
| 110 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.49556998 |
| 111 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.49498647 |
| 112 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.49180243 |
| 113 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.48362241 |
| 114 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.47273126 |
| 115 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.46762045 |
| 116 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.46607568 |
| 117 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.45014825 |
| 118 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.44590156 |
| 119 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.43390423 |
| 120 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.42301726 |
| 121 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.41500484 |
| 122 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.41497778 |
| 123 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.39604625 |
| 124 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.37402591 |
| 125 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.35893510 |
| 126 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.35686491 |
| 127 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.34473362 |

